logo
Create a cosy winter hideaway with indoor plants

Create a cosy winter hideaway with indoor plants

The Citizen11-07-2025
Winter can be a cold, dull season, with very little sign of life outdoors and homes that feel equally chilly. Just adding colour, especially colourful winter throws and cosy knee blankets are warm on the eye while indoor plants and flowers bring a room to life. Another bonus of indoor plants is that they keep the air fresh and improve humidity when windows and doors are kept closed.
Make the most of sunny rooms and windowsills, by adding flowering plants and succulents that enjoy the milder winter sun. Zantedeschia, chrysanthemums, anthuriums, kalanchoe and calandiva, as well as Gymnocalycium cactus will provide long lasting winter colour. While cyclamen like a cooler spot they will also thrive in sunny room as long as they are not in direct sun. Indoor flowering plants should have consistently moist but not soggy soil. Cut off dead flowers to encourage new flowers.
Calla lilies (Zantedeschia) add indoor warmth with their vivid colours. Plants grown indoors can bloom for up to six weeks. Feed with a liquid fertiliser once a month and remove spent blooms to encourage new blooms. True to their tropical nature, these mini lilies flower best in a warm, bright room and can take some morning sun.
Bold and big
Big leaved feature plants like Monstera deliciosa, Alocasia, Ficus robusta and Ficus lyrata always make a statement and effortlessly add that missing element to a well-furnished living room. These are all tropical plants that need a warm room and medium light. Water when the potting soil feels moderately dry.
Alocasia 'Red Secret' has large leaves with an intriguing texture and colour. The upper side of the heart-shaped leaf has a metallic, bronze glow, but its 'secret' is the burgundy red under leaf. It is easier to grow than it looks and its strong point is that it adapts to different light conditions, growing faster with bright light and slower with low light.
Bathroom forest
Plants that love humidity are perfect for steamy bathrooms and showers. Why not try the jungle look to transform your bathroom. Indulge in a long, hot soak and imagine yourself in some tropical paradise. Think ferns like Bird's nest fern (Asplenium) or Maidenhair fern (Adiantum) as well as leafy plants like Spathiphyllum (peace lily), Ficus Lyrata, Delicious monster and even Strelitzia. For a trailing effect try string of turtles (Peperomia prostrata). All these plants like medium light and can tolerate low light.
Sweet dreams
Plants that release oxygen at night and remove toxins from the air are especially good for bedrooms and one of these is Sansevieria, also known as mother-in-law tongue.
Basically, the stomata on Sansevieria leaves stay closed during the day to prevent evaporation and loss of water, and only open at night releasing all the stored oxygen. It will survive almost anywhere. It will take low light, cool temperatures, and dry soil very well.
Cascading beauties
Trailing plants don't necessarily have to trail although that is part of their charm. They can be trimmed to fill a hanging basket or to reduce their spread to fit into a smaller space. They are great for adding greenery in corners, higher up on bookshelves or spilling over the edge of a container or coffee table.
Most trailing plants need warmth and medium to bright indirect light.Don't neglect watering as it is easy to forget to water less accessible plants. However, most don't like to be over watered.
For a luxuriant effect there is Golden Pothos (Scindapsus Aureus) or the heart leaf plant (Philodendron scandens). Peperomia Angulata is a trailing peperomia with light greens stripes on its bright green oval leaves and Peperomia prostrata, also known as 'String of Turtles' is a really quaint trailing plant that is idea for baskets.
For more details: www.lvgplant.co.za
For more on gardening, visit Get It Magazine.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

🚨 Napoli end pre-season with narrow victory over Olympiacos
🚨 Napoli end pre-season with narrow victory over Olympiacos

Yahoo

time12 minutes ago

  • Yahoo

🚨 Napoli end pre-season with narrow victory over Olympiacos

Serie A title holders Napoli have rounded off their pre-season preparations with a narrow 2-1 victory over Greek side Politano 16', Lucca 53' ; Chiquinho 90' Antonio Conte's side opened the scoring in the first half with an effort from winger Matteo Politano. There was concern for the hosts before the break, however, as striker Romelu Lukaku was forced off with what appeared to be a thigh problem. His replacement, Lorenzo Lucca, scored Napoli's second and final goal of the evening early in the second-half, following some clever play from Kevin De Bruyne. Conte's side appeared to be heading for a clean sheet, but conceded a late consolation as the clock ticked over into stoppage time, stemming from a Vanja Milinković-Savić mistake. Napoli will begin their Serie A title defence next weekend with a trip to face Sassuolo. Their first five league fixtures also includes tricky tests against Fiorentina and AC Milan. 📸 Giuseppe Bellini - 2025 Getty Images

ImmunityBio (IBRX) Jumps 14% as on Promising Therapy Candidate Results
ImmunityBio (IBRX) Jumps 14% as on Promising Therapy Candidate Results

Yahoo

time12 minutes ago

  • Yahoo

ImmunityBio (IBRX) Jumps 14% as on Promising Therapy Candidate Results

We recently published . ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best-performing stocks on Wednesday. ImmunityBio soared by 14.17 percent on Wednesday to close at $2.82 apiece as investors cheered promising early findings from its ongoing trial (QUILT-106) to treat a rare blood cancer type with its therapy candidate. In a statement, ImmunityBio, Inc. (NASDAQ:IBRX) said the first phase of QUILT-106 showed highly promising results in the first two patients with Waldenstrom macroglobulinemia (WM)—a type of non-Hodgkins lymphoma (NHL)—using its CD19 CAR-NK (CD19 t-haNK) natural killer cell therapy. The trial aims to evaluate the safety and efficacy of the cell therapy alone, as well as when it is combined with an existing drug called rituximab. According to ImmunityBio, Inc. (NASDAQ:IBRX), both patients tolerated the therapy candidate without any significant side effects. Notably, all infusions were administered in an outpatient setting. Copyright: katrintimoff / 123RF Stock Photo 'One patient achieved a complete response (CR) with CD19 CAR NK monotherapy, while the second patient achieved CR with CD19 CAR-NK in combination with rituximab. Remission was maintained and is ongoing for six months to date,' ImmunityBio, Inc. (NASDAQ:IBRX) said. While we acknowledge the potential of IBRX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

If You Bought 100 Shares of Applied Digital at Its IPO, Here's How Much Money You'd Have Now
If You Bought 100 Shares of Applied Digital at Its IPO, Here's How Much Money You'd Have Now

Yahoo

time12 minutes ago

  • Yahoo

If You Bought 100 Shares of Applied Digital at Its IPO, Here's How Much Money You'd Have Now

Key Points Applied Digital had its initial public offering in April 2022 and was initially focused on blockchain and cryptocurrency mining operations. The company's strengths in processing hardware allowed it to easily pivot into the AI data center space. Applied Digital has delivered strong post-IPO gains, and the company recently scored some big wins. 10 stocks we like better than Applied Digital › Applied Digital (NASDAQ: APLD) stock had its initial public offering (IPO) in April 2022, although the company was known as Applied Blockchain at the time of its public debut. The company's share price has seen some big swings in the intervening years, but it has also delivered big wins for patient investors. Applied Digital stock closed out its first day of trading after its IPO priced at $4.85 per share. A purchase of 100 shares at that price would have been equivalent to an investment of $485. Compared to Applied Digital's stock price at market close on the day of its public debut, the company's share price is now up roughly 205%. That means that an investor who purchased 100 shares of the company's stock at its IPO would now be sitting on a position worth roughly $1,480. Read on for a closer look at the data center specialist's big performance drivers across the stretch and what's on the horizon for the business. How did Applied Digital stock deliver big gains -- and what comes next? Applied Digital got its start as a company that was focused on blockchain and cryptocurrency mining operations. Luckily for the company, the key graphics processing unit (GPU) hardware that is useful for mining cryptocurrencies is also at the heart of processing for artificial intelligence (AI) model training. With the AI revolution gaining steam in recent years, Applied Digital stock has seen a strong uptick in bullish momentum. Applied Digital stock also saw big gains in November 2024 in conjunction with news that Nvidia had taken an investment position in the company. While the company's share price has seen high levels of volatility since its public debut, shares are up roughly 282% over the last year of trading. Applied Digital stock has recently seen big gains thanks to news that CoreWeave has opted to exercise an option that it had to expand data center licensing through the company. With CoreWeave ramping up its data center utilization, Applied Digital's growth outlook has become much stronger. Should you invest $1,000 in Applied Digital right now? Before you buy stock in Applied Digital, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Applied Digital wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $649,544!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,113,059!* Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy. If You Bought 100 Shares of Applied Digital at Its IPO, Here's How Much Money You'd Have Now was originally published by The Motley Fool Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store